congenital dyserythropoietic anemia type ii cda ii hereditary erythroblastic multinuclearity positive acidified serum lysis test rare genetic anemia humans characterized hereditary erythroblastic multinuclearity positive acidified serum lysis cda type ii caused mutations gene gene provides instructions making protein involved transport proteins within cells development red blood cells protein may help ensure proteins transported areas needed researchers working determine mutations gene lead signs symptoms cda type analyses cda ii erythrocyte membranes showed band glycoprotein underglycosylated aberrant glycosylation pattern seen polylactosamine carbohydrates normally attached band band glycoproteins polylactosamines however accumulated form glycolipids therefore genetic factor cda ii appears block glycosylation protein acceptors shift carbohydrates lipid acceptors structural analysis cda ii band carbohydrates identified truncated hybridtype oligosaccharides suggests golgi glycosylation enzymes alphamannosidase ii nacetylglycosaminyltransferase ii defective cda anemia associated cda type ii range mild severe affected individuals jaundice hepatosplenomegaly formation hard deposits gallbladder called bilirubin gallstones form disorder usually diagnosed adolescence early adulthood abnormal buildup iron typically occurs age leading complications including heart disease diabetes treatment consists frequent blood transfusions chelation therapy potential cures include bone marrow transplantation gene therapycitation needed httpsenwikipediaorgwikicongenitaldyserythropoieticanemiatypeii